Azaiez Hela, Yang Tao, Prasad Sai, Sorensen Jessica L, Nishimura Carla J, Kimberling William J, Smith Richard J H
Molecular Otolaryngology Research Laboratories, Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, 200 Hawkins Dr, Iowa City, IA 52242, USA.
Hum Genet. 2007 Dec;122(5):451-7. doi: 10.1007/s00439-007-0415-2. Epub 2007 Aug 10.
Pendred syndrome (PS) and non-syndromic enlarged vestibular aqueduct (EVA) are two recessive disorders characterized by the association of sensorineural hearing loss (SNHL) with inner ear malformations that range from isolated EVA to Mondini Dysplasia, a complex malformation that includes a cochlear dysplasia and EVA. Mutations in the SLC26A4 gene, coding for the protein pendrin, have been implicated in the pathophysiology of both disorders. In order to determine whether SLC26A4 genotypes can be correlated to the complexity and severity of the phenotypes, we ascertained 1,506 deaf patients. Inner ear abnormalities were present in 474 patients (32%). Mutation screening of SLC26A4 detected two mutations in 16% of patients, one mutation in 19% of patients and zero mutation in 65% of patients. When the distribution of SLC26A4 genotypes was compared across phenotypes, a statistically significant difference was found between PS patients and non-syndromic EVA-Mondini patients (P = 0.005), as well as between EVA patients and Mondini patients (P = 0.0003). There was a correlation between phenotypic complexity of inner ear malformations and genetic heterogeneity--PS patients have the most severe phenotype and the most homogeneous etiology while EVA patients have the least severe phenotype and the most heterogeneous etiology. For all patients, variability in the degree of hearing loss is seen across genotypes implicating other genetic and/or environmental factors in the pathogenesis of the PS-Mondini-EVA disease spectrum.
彭德莱德综合征(PS)和非综合征性大前庭导水管(EVA)是两种隐性疾病,其特征是感音神经性听力损失(SNHL)与内耳畸形相关,内耳畸形范围从孤立的EVA到Mondini发育异常,后者是一种复杂畸形,包括耳蜗发育异常和EVA。编码pendrin蛋白的SLC26A4基因突变与这两种疾病的病理生理机制有关。为了确定SLC26A4基因型是否与表型的复杂性和严重程度相关,我们确定了1506名耳聋患者。474名患者(32%)存在内耳异常。SLC26A4突变筛查发现,16%的患者有两个突变,19%的患者有一个突变,65%的患者无突变。当比较不同表型的SLC26A4基因型分布时,发现PS患者与非综合征性EVA-Mondini患者之间存在统计学显著差异(P = 0.005),EVA患者与Mondini患者之间也存在统计学显著差异(P = 0.0003)。内耳畸形的表型复杂性与遗传异质性之间存在相关性——PS患者的表型最严重,病因最单一,而EVA患者的表型最不严重,病因最具异质性。对于所有患者,不同基因型的听力损失程度存在差异,这表明在PS-Mondini-EVA疾病谱的发病机制中存在其他遗传和/或环境因素。